Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.34 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28366793 | 1.00 | CYP2C9 (0.40) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL30309465 | 1.00 | CYP2C9 (0.40) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL28382459 | 0.96 | CYP2C9 (0.41) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL2392780 | 0.91 | CYP2C9 (0.49) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL6558027 | 0.91 | CYP2C9 (0.49) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL30400657 | 0.91 | CYP2C9 (0.49) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL12622943 | 0.90 | CYP2C9 (0.40) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL8222398 | 0.89 | CYP2C9 (0.48) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL8222400 | 0.89 | CYP2C9 (0.48) | CYP2C9MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL8222402 | 0.89 | CYP2C9 (0.48) | CYP2C9MAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111770909-B | Polymerizable compound, liquid crystal composition using same, and liquid crystal display element | DIC株式会社 | 2024-01-30 | — | — | CN | disclosed |
| US-11760934-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used | DIC CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11760934-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used | DIC CORPORATION (JP) | 2023-09-19 | — | — | US | disclosed |
| CN-110573490-B | Polymerizable compound and liquid crystal composition | DIC株式会社（JP） | 2023-01-13 | — | — | CN | disclosed |
| CN-111194305-B | Polymerizable compound, and liquid crystal composition and liquid crystal display element using same | DIC株式会社 | 2023-01-03 | — | — | CN | disclosed |
| CN-111770909-A | Polymerizable compound, and liquid crystal composition and liquid crystal display element using same | DIC株式会社 | 2020-10-13 | — | — | CN | disclosed |
| US-20200308488-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT IN WHICH THE COMPOUND IS USED | DIC CORPORATION (JP) | 2020-10-01 | — | — | US | disclosed |
| CN-111194305-A | Polymerizable compound, and liquid crystal composition and liquid crystal display element using same | DIC株式会社 | 2020-05-22 | — | — | CN | disclosed |
| CN-110573490-A | Polymerizable compound and liquid crystal composition | DIC株式会社 | 2019-12-13 | — | — | CN | disclosed |
| US-8211513-B2 | Liquid-crystalline compounds and liquid-crystalline media | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-07-03 | — | — | US | disclosed |
| US-20110233466-A1 | LIQUID-CRYSTALLINE COMPOUNDS AND LIQUID-CRYSTALLINE MEDIA | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-09-29 | — | — | US | disclosed |
| EP-2368966-A1 | Liquid crystalline compounds and liquid crystalline media | Merck Patent GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760934-B2 | Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used | SFXN1, SFXN3, SIK3 | CYP2C9 1642/4885MAPT 4455/4885MEN1 3058/4885 |
| US-20200308488-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT IN WHICH THE COMPOUND IS USED | SFXN1, SFXN3, SIK3 | CYP2C9 1642/4885MAPT 4455/4885MEN1 3058/4885 |
| US-20110233466-A1 | LIQUID-CRYSTALLINE COMPOUNDS AND LIQUID-CRYSTALLINE MEDIA | CFB, CFD, LCT | CYP2C9 1926/4885MAPT 188/4885MEN1 1993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.